United Therapeutics Corporation (OQ:UTHR)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for UTHR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -3,596 $117.61
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -6,404 $117.13
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $63.22
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Stock Options M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -681 $119.23
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -3,128 $118.23
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -6,191 $117.46
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Stock Options M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $63.22
May 20/20 May 20/20 Rothblatt Martine A Direct Ownership Stock Options M - Exercise or conversion exempt under rule 16b-3 -10,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for UTHR within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -3,596 $117.61
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -6,404 $117.13
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $63.22
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -681 $119.23
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -3,128 $118.23
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -6,191 $117.46
May 22/20 May 22/20 Rothblatt Martine A Direct Ownership Stock Options M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Stock Options M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 22/20 May 21/20 Rothblatt Martine A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $63.22
May 20/20 May 19/20 Rothblatt Martine A Direct Ownership Common Stock S - Open market or private sale -1,135 $123.22
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $UTHR

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)